Managing osteoporosis in patients with fragility fractures: did the British Orthopaedic Association guidelines have any impact?
BACKGROUND
The incidence of fragility fractures could double in the next 50 years. Effective treatments for osteoporosis exist and the British Orthopaedic Association (BOA) has guidelines governing how to manage underlying osteoporosis in patients with fragility fractures. This study assessed how well two trauma units treat underlying osteoporosis and whether the BOA guidelines made any impact.


METHODS
Case notes of patients with a fracture of their proximal femur admitted during January and February in 2003, 2004 and 2005 were reviewed. The results were analysed for differences between site and year.


RESULTS
A total of 602 case notes were reviewed. There was a significant difference in the number of patients discharged on osteoporosis medication between the two sites (27% at LRI, 8% at KGH; P < 0.001), but not between 2003 and 2005 (22% and 16%; P = 0.16). Of the patients started on treatment, 83% were started on calcium and/or vitamin D(3) supplements.


CONCLUSIONS
The number of patients who had their underlying osteoporosis addressed was low and the type of treatment sub-optimal. This suggests the BOA guidelines have not made an impact and further work is required to improve the management of these patients.
Nixon
M F
MF
Department of Orthopaedic Surgery, University Hospitals of Leicester NHS Trust, Leicester Royal Infirmary, Leicester, UK. mfnixon@gmail.com
Ibrahim
T
T
Johari
Y
Y
Eltayef
S
S
Hariharan
D
D
Taylor
G J
GJ
D000368:Aged; D000369:Aged, 80 and over; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D005264:Femoral Fractures / Q000601:surgery*; D005598:Fractures, Spontaneous / Q000209:etiology / Q000601:surgery*; D006801:Humans; D007902:Length of Stay; D008875:Middle Aged; D010024:Osteoporosis / Q000150:complications*; D011182:Postoperative Care / Q000706:statistics & numerical data; D017410:Practice Guidelines as Topic; D011300:Preoperative Care / Q000706:statistics & numerical data; D011364:Professional Practice; D012307:Risk Factors; D014850:Waiting Lists
D050071:Bone Density Conservation Agents; D004164:Diphosphonates
Ugeskr Laeger. 2002 Jul 1;164(27):3541-4
12116684
BMJ. 1999 Nov 20;319(7221):1350-2
10567145
Clin Orthop Relat Res. 2003 Mar;(408):268-78
12616070
Intern Med J. 2004 Mar;34(3):129-32
15030462
J Pharmacol Toxicol Methods. 2004 Jul-Aug;50(1):25-34
15233964
Injury. 1982 Nov;14(3):207-10
7152645
Lancet. 1985 Jan 19;1(8421):150-1
2857223
J Orthop Res. 1985;3(4):499-507
3934355
N Engl J Med. 1992 Dec 3;327(23):1637-42
1331788
Arch Orthop Trauma Surg. 1993;112(5):228-31
8217459
Bone. 1994 Nov-Dec;15(6):701-5
7873300
Pharmacol Toxicol. 1994 Dec;75(6):384-90
7899261
Age Ageing. 1995 May;24(3):185-9
7645435
J Orthop Res. 1996 Jan;14(1):74-9
8618170
Arch Orthop Trauma Surg. 1996;115(2):111-4
9063849
Acta Orthop Scand. 1998 Oct;69(5):532-6
9855239
J Bone Miner Res. 1999 Jun;14(6):969-79
10352106
J Bone Joint Surg Am. 2005 Jan;87(1):3-7
15634808
Lancet. 2005 May 7-13;365(9471):1621-8
15885294
Int J Clin Pract. 2002 Oct;56(8):620-1
12425375